Kristen Underhill1, Atheendar Venkataramani1, Kevin G Volpp1. 1. From Columbia Law School and the Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York (K.U.); and the Department of Medical Ethics and Health Policy and Department of Medicine, Perelman School of Medicine (A.V., K.G.V.),the Department of Health Care Management, Wharton School (K.G.V.), and the Center for Health Incentives and Behavioral Economics-National Institute of Aging Roybal Center on Behavioral Economics and Health (K.U., A.V., K.G.V.), University of Pennsylvania, and the Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center (K.G.V.) - all in Philadelphia. The authors are the principal investigators of the independent evaluation team assessing Kentucky's Section 1115 waiver initiative; other team members are Kristin Linn, Erica Dixon, Elizabeth Bair, Will Ferrell, and Genevieve Kanter.
Authors: Kristin A Linn; Kristen Underhill; Erica L Dixon; Elizabeth F Bair; William J Ferrell; Margrethe E Montgomery; Kevin G Volpp; Atheendar S Venkataramani Journal: Contemp Clin Trials Date: 2020-10-07 Impact factor: 2.226